Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injections and via the Port Delivery (PD) implant in participants with neovascular age-related macular degeneration (nAMD).
Sponsor: Hoffmann-La Roche
Check if you qualify for this macular degeneration clinical trial in Phoenix, AZ
If you're searching for macular degeneration treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.